Rutin as Neuroprotective Agent: From Bench to Bedside.


Journal

Current medicinal chemistry
ISSN: 1875-533X
Titre abrégé: Curr Med Chem
Pays: United Arab Emirates
ID NLM: 9440157

Informations de publication

Date de publication:
2019
Historique:
received: 16 12 2016
revised: 20 09 2017
accepted: 22 09 2017
pubmed: 4 10 2017
medline: 27 11 2019
entrez: 4 10 2017
Statut: ppublish

Résumé

Flavonoids are major dietary constituents of plant-based food found ubiquitously in plant kingdom where they are usually present in substantial amounts. Rutin is a flavonol-type polyphenol which consists of the flavonol quercetin and the disaccharide rutinose. Rutin has been reported to exert diverse biological effects such as antitumor and antimicrobial mainly associated to its antioxidant and anti-inflammatory activities. Mental, neurological, and behavioural disorders are an important and growing cause of morbidity. Most of these disorders combine a high prevalence, early onset, progressive clinical course, and impairment of critical brain functions making them a major contributor to the global disease burden. In the present work, the biological in vitro and in vivo effects and the potential therapeutic applications of rutin in neurodegenerative processes are reviewed, as well as their bioavailability and pharmacokinetics, which are essential for a better understanding of its biological effectiveness. Moreover, the present review also provides an overview of the molecular mechanisms through which rutin is proposed to exert its neuroprotective effects.

Identifiants

pubmed: 28971760
pii: CMC-EPUB-86144
doi: 10.2174/0929867324666171003114154
doi:

Substances chimiques

Neuroprotective Agents 0
Rutin 5G06TVY3R7

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

5152-5164

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Barbara Budzynska (B)

Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, Chodzki 4a Street, 20- 093 Lublin, Poland.

Caterina Faggio (C)

Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina Viale Ferdinando Stagno d'Alcontres, 31 98166, S.Agata, Messina, Italy.

Marta Kruk-Slomka (M)

Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, Chodzki 4a Street, 20- 093 Lublin, Poland.

Dunja Samec (D)

Department of Molecular Biology, Institute Ruder Boskovic, Bijenicka c. 54, 10000 Zagreb, Croatia.

Seyed Fazel Nabavi (SF)

Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Antoni Sureda (A)

Research Group on Community Nutrition and Oxidative Stress (NUCOX), University of Balearic Islands, E-07122 Palma de Mallorca, Balearic Islands, Spain.
CIBEROBN (Physiopathology of Obesity and Nutrition), E-07122 Palma de Mallorca, Balearic Islands, Spain.

Kasi Pandima Devi (KP)

Department of Biotechnology, Alagappa University, Karaikudi 630 004, Tamil Nadu, India.

Seyed Mohammad Nabavi (SM)

Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH